A role for galanin in human and experimental inflammatory demyelination
about
Generating orally active galanin analogues with analgesic activitiesGalanin transgenic mice with elevated circulating galanin levels alleviate demyelination in a cuprizone-induced MS mouse modelCharacterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice.Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotypeIdentification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis.Involvement of calcitonin gene-related peptide and receptor component protein in experimental autoimmune encephalomyelitis.G protein-coupled receptors as therapeutic targets for multiple sclerosis.Weakened cholinergic blockade of inflammation associates with diabetes-related depression.Murine Cytomegalovirus Infection Induces Susceptibility to EAE in Resistant BALB/c Mice.Galanin receptors as a potential target for neurological disease.Single-nucleotide polymorphism rs948854 in human galanin gene and multiple sclerosis: a gender-specific risk factor.Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinomaTemporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.Prolonged stimulation of a brainstem raphe region attenuates experimental autoimmune encephalomyelitis.Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
P2860
Q28260945-FC314470-2BD6-4CFC-8DE2-0034AE56F2E2Q28731222-CD71D673-08C9-4113-8BFF-AF6751E73A26Q34297217-32EE2A35-713F-4E70-A90E-A1E8536B6DDEQ34428400-2FF0B77B-5947-4F02-A0BC-36A7E5C68349Q34695691-0AF1F4ED-5047-4773-BC2B-86C2826CF0D6Q35799802-0CE77145-DC99-4275-B078-509D91ED87F0Q37112554-090A3AAD-1C6D-4379-BD04-98E61BDC4126Q37217051-6DF97A77-AD5A-4088-A4D9-57B283A7BF78Q37667382-C2FD18FE-943E-4BC3-9E07-C4579971A7A8Q38556483-1B11811A-0AF9-49A6-99AB-C6BF0C837C8CQ39168246-C17B4F55-97C5-477C-A30F-3E23A40B9926Q39587210-7DC29CE1-9A5E-428C-8F65-C45922E8C70AQ47794368-C3F3E244-88AE-4B32-9009-FC1E30D5E761Q48329616-1CFAE604-55A1-4018-879F-28B9BC8B8C26Q48350319-677834B0-0623-4208-8304-6A6DCEF548EB
P2860
A role for galanin in human and experimental inflammatory demyelination
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role for galanin in human and experimental inflammatory demyelination
@en
A role for galanin in human and experimental inflammatory demyelination.
@nl
type
label
A role for galanin in human and experimental inflammatory demyelination
@en
A role for galanin in human and experimental inflammatory demyelination.
@nl
prefLabel
A role for galanin in human and experimental inflammatory demyelination
@en
A role for galanin in human and experimental inflammatory demyelination.
@nl
P2093
P2860
P50
P356
P1476
A role for galanin in human and experimental inflammatory demyelination
@en
P2093
Andrew L Gundlach
David C Wraith
David Wynick
Heidi Holder
Michael J Day
Pauline Lowrey
Penny Vanderplank
Robert Pope
P2860
P304
15466-15471
P356
10.1073/PNAS.0903360106
P407
P577
2009-08-26T00:00:00Z